VIVA 2019: New Paclitaxel Data Shows Consistent Mortality Signal, No Clear Cause

Research investigating outcomes in patients treated with paclitaxel-coated devices demonstrated a consistent if modest mortality signal when compared to bare-metal stents. However, the signal was not seen in real-world data, and some researchers question whether the signal might stem from problems in the original trials.